Epigral Ltd
NSE:EPIGRAL

Watchlist Manager
Epigral Ltd Logo
Epigral Ltd
NSE:EPIGRAL
Watchlist
Price: 1 946.65 INR 0.91% Market Closed
Market Cap: 84B INR
Have any thoughts about
Epigral Ltd?
Write Note

Epigral Ltd
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Epigral Ltd
Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Epigral Ltd
NSE:EPIGRAL
Cash Equivalents
â‚ą67.9m
CAGR 3-Years
198%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Supreme Industries Ltd
NSE:SUPREMEIND
Cash Equivalents
â‚ą6.8B
CAGR 3-Years
26%
CAGR 5-Years
41%
CAGR 10-Years
38%
Tata Chemicals Ltd
NSE:TATACHEM
Cash Equivalents
â‚ą6.5B
CAGR 3-Years
-23%
CAGR 5-Years
-20%
CAGR 10-Years
-10%
Deepak Nitrite Ltd
NSE:DEEPAKNTR
Cash Equivalents
â‚ą2.1B
CAGR 3-Years
84%
CAGR 5-Years
132%
CAGR 10-Years
N/A
Berger Paints India Ltd
NSE:BERGEPAINT
Cash Equivalents
â‚ą620.2m
CAGR 3-Years
-48%
CAGR 5-Years
-24%
CAGR 10-Years
-10%
Solar Industries India Ltd
NSE:SOLARINDS
Cash Equivalents
â‚ą274m
CAGR 3-Years
34%
CAGR 5-Years
-2%
CAGR 10-Years
-15%
No Stocks Found

Epigral Ltd
Glance View

Market Cap
80.9B INR
Industry
Chemicals

Meghmani Finechem Ltd. engages in the manufacture of chemicals involved in pigments and pesticides. The company is headquartered in Ahmedabad, Gujarat and currently employs 936 full-time employees. The company went IPO on 2021-08-18. The firm is engaged in manufacturing and selling chlor alkali and its derivatives. The company is also engaged in the trading of agrochemical products. The firm manufactures a range of products, such as chlorinated polyvinyl chloride (CPVC) resin, caustic soda, caustic potash, chlorine, hydrogen, chloromethanes, and hydrogen peroxide. The Company’s products are used in alumina, textile, crop protection, refineries, pharmaceutical, paper & pulp, soaps & detergent, and other industries. The Company’s subsidiaries include Meghmani Advanced Sciences Limited.

EPIGRAL Intrinsic Value
1 729.35 INR
Overvaluation 11%
Intrinsic Value
Price

See Also

What is Epigral Ltd's Cash Equivalents?
Cash Equivalents
67.9m INR

Based on the financial report for Mar 31, 2024, Epigral Ltd's Cash Equivalents amounts to 67.9m INR.

What is Epigral Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 3Y
198%

Over the last year, the Cash Equivalents growth was -55%. The average annual Cash Equivalents growth rates for Epigral Ltd have been 198% over the past three years .

Back to Top